140 related articles for article (PubMed ID: 34995935)
21. Early Activation of Myeloid-Derived Suppressor Cells Participate in Sepsis-Induced Immune Suppression via PD-L1/PD-1 Axis.
Ruan WS; Feng MX; Xu J; Xu YG; Song CY; Lin LY; Li L; Lu YQ
Front Immunol; 2020; 11():1299. PubMed ID: 32719675
[No Abstract] [Full Text] [Related]
22. Expression of Cationic Amino Acid Transporter 2 Is Required for Myeloid-Derived Suppressor Cell-Mediated Control of T Cell Immunity.
Cimen Bozkus C; Elzey BD; Crist SA; Ellies LG; Ratliff TL
J Immunol; 2015 Dec; 195(11):5237-50. PubMed ID: 26491198
[TBL] [Abstract][Full Text] [Related]
23. Tumour YAP1 and PTEN expression correlates with tumour-associated myeloid suppressor cell expansion and reduced survival in colorectal cancer.
Yang R; Cai TT; Wu XJ; Liu YN; He J; Zhang XS; Ma G; Li J
Immunology; 2018 Oct; 155(2):263-272. PubMed ID: 29770434
[TBL] [Abstract][Full Text] [Related]
24. l-arginine and docetaxel synergistically enhance anti-tumor immunity by modifying the immune status of tumor-bearing mice.
Cao Y; Wang Q; Du Y; Liu F; Zhang Y; Feng Y; Jin F
Int Immunopharmacol; 2016 Jun; 35():7-14. PubMed ID: 27003114
[TBL] [Abstract][Full Text] [Related]
25. Myeloid-Derived Suppressor Cells in
Fresno M; Gironès N
Front Cell Infect Microbiol; 2021; 11():737364. PubMed ID: 34513737
[TBL] [Abstract][Full Text] [Related]
26. Elevated levels of polymorphonuclear myeloid-derived suppressor cells in patients with glioblastoma highly express S100A8/9 and arginase and suppress T cell function.
Gielen PR; Schulte BM; Kers-Rebel ED; Verrijp K; Bossman SA; Ter Laan M; Wesseling P; Adema GJ
Neuro Oncol; 2016 Sep; 18(9):1253-64. PubMed ID: 27006175
[TBL] [Abstract][Full Text] [Related]
27. Granulocytic myeloid-derived suppressor cells maintain feto-maternal tolerance by inducing Foxp3 expression in CD4+CD25-T cells by activation of the TGF-β/β-catenin pathway.
Kang X; Zhang X; Liu Z; Xu H; Wang T; He L; Zhao A
Mol Hum Reprod; 2016 Jul; 22(7):499-511. PubMed ID: 27016139
[TBL] [Abstract][Full Text] [Related]
28. Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3.
Trovato R; Fiore A; Sartori S; Canè S; Giugno R; Cascione L; Paiella S; Salvia R; De Sanctis F; Poffe O; Anselmi C; Hofer F; Sartoris S; Piro G; Carbone C; Corbo V; Lawlor R; Solito S; Pinton L; Mandruzzato S; Bassi C; Scarpa A; Bronte V; Ugel S
J Immunother Cancer; 2019 Sep; 7(1):255. PubMed ID: 31533831
[TBL] [Abstract][Full Text] [Related]
29. l-Arginine depletion blunts antitumor T-cell responses by inducing myeloid-derived suppressor cells.
Fletcher M; Ramirez ME; Sierra RA; Raber P; Thevenot P; Al-Khami AA; Sanchez-Pino D; Hernandez C; Wyczechowska DD; Ochoa AC; Rodriguez PC
Cancer Res; 2015 Jan; 75(2):275-83. PubMed ID: 25406192
[TBL] [Abstract][Full Text] [Related]
30. Myeloid-Derived Suppressor Cells Mediate Immunosuppression After Cardiopulmonary Bypass.
Hübner M; Tomasi R; Effinger D; Wu T; Klein G; Bender M; Kilger E; Juchem G; Schwedhelm E; Kreth S
Crit Care Med; 2019 Aug; 47(8):e700-e709. PubMed ID: 31149961
[TBL] [Abstract][Full Text] [Related]
31. PMN-MDSCs Enhance CTC Metastatic Properties through Reciprocal Interactions via ROS/Notch/Nodal Signaling.
Sprouse ML; Welte T; Boral D; Liu HN; Yin W; Vishnoi M; Goswami-Sewell D; Li L; Pei G; Jia P; Glitza-Oliva IC; Marchetti D
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31003475
[TBL] [Abstract][Full Text] [Related]
32. Myeloid-Derived Suppressor Cells in Lung Transplantation.
Heigl T; Singh A; Saez-Gimenez B; Kaes J; Van Herck A; Sacreas A; Beeckmans H; Vanstapel A; Verleden SE; Van Raemdonck DE; Verleden G; Vanaudenaerde BM; Hartl D; Vos R
Front Immunol; 2019; 10():900. PubMed ID: 31080450
[TBL] [Abstract][Full Text] [Related]
33. OLFM4 deficiency delays the progression of colitis to colorectal cancer by abrogating PMN-MDSCs recruitment.
Chen Z; Zhang X; Xing Z; Lv S; Huang L; Liu J; Ye S; Li X; Chen M; Zuo S; Tao Y; He Y
Oncogene; 2022 May; 41(22):3131-3150. PubMed ID: 35487976
[TBL] [Abstract][Full Text] [Related]
34. Clinical and prognostic significance of CD14 (+) HLA-DR (-/low) myeloid-derived suppressor cells in patients with hepatocellular carcinoma received transarterial radioembolization with Yttrium-90.
Boral B; Ballı HT; Sözütok S; Pehlivan UA; Aikimbaev K
Scand J Immunol; 2022 Mar; 95(3):e13132. PubMed ID: 34936119
[TBL] [Abstract][Full Text] [Related]
35. Blood Myeloid-Derived Suppressor Cells Correlate with Neutrophil-to-Lymphocyte Ratio and Overall Survival in Metastatic Urothelial Carcinoma.
Sheng IY; Diaz-Montero CM; Rayman P; Wei W; Finke JH; Kim JS; Pavicic PG; Lamenza M; Company D; Stephenson A; Campbell S; Haber G; Lee B; Mian O; Gilligan TD; Rini BI; Garcia JA; Grivas P; Ornstein MC
Target Oncol; 2020 Apr; 15(2):211-220. PubMed ID: 32207064
[TBL] [Abstract][Full Text] [Related]
36. Human splenic polymorphonuclear myeloid-derived suppressor cells (PMN-MDSC) are strategically located immune regulatory cells in cancer.
Tavukcuoglu E; Horzum U; Yanik H; Uner A; Yoyen-Ermis D; Nural SK; Aydin B; Sokmensuer C; Karakoc D; Yilmaz KB; Hamaloglu E; Esendagli G
Eur J Immunol; 2020 Dec; 50(12):2067-2074. PubMed ID: 32691408
[TBL] [Abstract][Full Text] [Related]
37. Expansion and activation of monocytic-myeloid-derived suppressor cell via STAT3/arginase-I signaling in patients with ankylosing spondylitis.
Liu YF; Zhuang KH; Chen B; Li PW; Zhou X; Jiang H; Zhong LM; Liu FB
Arthritis Res Ther; 2018 Aug; 20(1):168. PubMed ID: 30075733
[TBL] [Abstract][Full Text] [Related]
38. Myeloid-Derived Suppressor Cells in Colorectal Cancer.
Sieminska I; Baran J
Front Immunol; 2020; 11():1526. PubMed ID: 32849517
[TBL] [Abstract][Full Text] [Related]
39. [Correlation analysis between the numbers of G-MDSCs and M-MDSCs in peripheral blood decrease and therapeutic effect in patients with colorectal cancer].
Wang Y; Xu L; Yun Z; Chu Y; Fa Z; Deng J; Zhang Y; Wu J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Jun; 34(6):546-551. PubMed ID: 30236209
[TBL] [Abstract][Full Text] [Related]
40. Expansion of Monocytic Myeloid-Derived Suppressor Cells in Patients Under Hemodialysis Might Lead to Cardiovascular and Cerebrovascular Events.
Xing YF; Cai JR; Qin JJ; Zhou WY; Li CM; Li X
Front Immunol; 2020; 11():577253. PubMed ID: 33584644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
